 |
About Us |
Berean Development, Inc.
Berean Development Inc. is dedicated to the research, development,
production and sale of bioceutical compounds effective in the
treatment of autoimmune disease. Berean targets its research to the
development of compounds whose mechanism of activity targets the
blocking of ion channels in certain lymphocytic T-Cells, thereby
prohibiting the cascade of events leading to inflammatory responses
seen in autoimmune type disease.
We are a biotechnology company focusing on the development and
commercialization of naturally occurring compounds for the treatment
of Diabetes (both Type I and Type II) Lupus, Fibromyalgia and
Arthritis. Developing products by reverse engineering the symplexes,
ligands and constellation of modalities that cascade and eventuate
into the expression of the Proto-Oncogene that causes these
diseases.
The chemical make-up of Berean’s complexes contains several
bioactive molecules that are proprietary to the Company as novel
immunotherapeutics. Over the past six years, Berean has been able to
research, synthesize and validate - in vitro and in vivo, in animals
and in man - the suppression of gene expression by blockade of
patented gene voltage-gated potassium channels. Berean’s key
bioactive ingredients effect the blockage of these channels, which
cause proliferation of the disease-signaling NK CD8 negative T-Cells. The
pathogeneses of these cells induce various autoimmune states today
known as diseases. Berean is now able to reverse and abate these
symptomatic disease states.
History
We have developed, through collaborative agreements, the
synthesis of our proprietary compounds. The synthesis allows us to
maintain constant efficacy and quality control, and to provide
patent “suites” to protect Berean’s position. Berean’s products are
protected under various US and foreign patents.
Mirac Customer Care
( 888-Mirac-11
(888-647-2211)
( 949-706-9075
email:
customercare@lupusremedy.com
|
